ORIENTAL YUHONG(SZ:002271) 光大证券研究·2025-03-06 09:25Core Viewpoint - The company reported a significant decline in revenue and net profit for the year 2024, primarily due to external demand pressures and strategic decisions to reduce direct sales, while retail and engineering channels showed growth [2][3]. Group 1: Financial Performance - In 2024, the company achieved revenue of 2.806 billion, a decrease of 14.5% year-on-year, with net profit attributable to shareholders dropping by 95.2% to 110 million [2]. - The fourth quarter saw revenue of 636 million, down 14.8% year-on-year, with a net loss attributable to shareholders of 1.17 billion [2][3]. - Operating cash flow for the year was 3.46 billion, an increase of 64.4% year-on-year [2]. Group 2: Revenue Breakdown - Retail channel revenue increased by 9.9% to 1.021 billion, accounting for 36.4% of total revenue, driven by product iteration and deeper channel penetration [3]. - Engineering channel revenue grew by 6.7% to 1.335 billion, supported by the promotion of a partner mechanism and product diversification [3]. - Direct sales revenue plummeted by 58.8% to 428 million as the company continued to shrink this segment [3]. Group 3: Profitability and Costs - The company's gross margin for 2024 was 25.8%, down 1.9 percentage points, primarily due to price adjustments and changes in product mix [4]. - The sales expense ratio increased to 10.3%, while management and R&D expense ratios rose to 6.4% and 2.1%, respectively, reflecting the impact of revenue decline [4]. - The net profit margin for the year was 0.3%, a decrease of 6.7 percentage points, influenced by asset impairment losses totaling 1.8 billion [4]. Group 4: Future Outlook - For 2025, the company anticipates improved governance and reduced pledge risks due to high dividends, alongside effective asset disposals that may alleviate remaining impairment risks [5]. - The company expects revenue stabilization and potential growth driven by the civil construction group and continued improvements in operational quality [5]. - Cost reduction and efficiency enhancement measures are anticipated to improve expense ratios, with remaining impairment risks expected to be released within the year [5].